Most cited journal articles published in 2022 on psychedelic therapy for cancer patients

Research on the use of psychedelics, such as psilocybin and LSD, for the treatment of anxiety and other mental health conditions in cancer patients is still in its early stages, but there is a growing body of evidence that suggests that these substances may have potential therapeutic benefits.

A number of recent studies have found that psychedelic therapy, specifically psilocybin therapy, can be effective in reducing symptoms of anxiety, depression, and PTSD in cancer patients. Psilocybin therapy has been found to produce changes in brain activity that are associated with decreased symptoms of anxiety, depression, and PTSD, and increased feelings of well-being and spiritual connectedness.

Additionally, research has shown that psilocybin therapy can lead to long-term changes in attitudes, mood, and behavior, which can be beneficial for cancer patients who are struggling with the emotional and psychological impact of their diagnosis.

It's important to note that research on psychedelic therapy for cancer patients is still in its early stages, and more research is needed to fully understand the potential benefits and risks of these treatments. Additionally, these substances are currently illegal in many countries and their use is not recommended outside of a clinical research setting.